Theriva Biologics
TOVX
TOVX
74 hedge funds and large institutions have $27.4M invested in Theriva Biologics in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
24% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 17
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
74
Holding in Top 10
1
Calls
$6.59M
Puts
–
Top Buyers
| 1 | +$3.52M | |
| 2 | +$1.66M | |
| 3 | +$70.6K | |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$52K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$44.3K |
Top Sellers
| 1 | -$1.55M | |
| 2 | -$1.02M | |
| 3 | -$356K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$271K |
| 5 |
Millennium Management
New York
|
-$242K |